Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Amazon launches first GBP bond issuance, four-part deal covers maturities from 3 to 19 years

Amazon launches first GBP bond issuance, four-part deal covers maturities from 3 to 19 years

智通财经智通财经2026/09/09 08:56
Show original
⑴ Amazon has launched its first sterling bond issuance, which is divided into four tranches with maturities ranging from 3 to 19 years. The initial pricing discussion for the shortest maturity bond is about 70 basis points above UK gilt yields, while the longest maturity bond is about 110 basis points higher. ⑵ JPMorgan, Barclays, HSBC, and NatWest Group are responsible for underwriting, and pricing is expected later on Wednesday. This is Amazon’s fourth bond issuance outside the US dollar market this year. ⑶ In March, the company issued its first euro-denominated bond, setting a record for corporate bond issuance in that currency. Subsequently, it set a record with six tranches in the Swiss franc market and completed the largest-ever Canadian dollar bond issuance. ⑷ Overall, Amazon is the largest bond issuer among hyperscale cloud service providers by 2026, having issued the equivalent of over $92 billion in bonds.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%

Researchers combined Amgen's Imdelltra with AstraZeneca's Imfinzi and found that for patients with aggressive lung cancer whose tumors had already spread, this combination extended survival by about eight months compared to Imfinzi monotherapy. Small cell lung cancer is one of the cancer types with the worst prognosis.

智通财经•2026/10/25 02:56
Amgen (AMGN.US) and AstraZeneca (AZN.US) combination therapy extends small cell lung cancer survival by eight months, reduces risk of death by 58%